Mark Gaffney
Amministratore Delegato presso Oxular Ltd.
Posizioni attive di Mark Gaffney
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | 11/09/2023 | - |
| Amministratore Delegato | 11/09/2023 | - |
Storia della carriera di Mark Gaffney
Precedenti posizioni note di Mark Gaffney
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Virtual Software Systems, Inc.
 Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Direttore/Membro del Consiglio | 01/03/2016 | 01/09/2017 |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Direttore operativo | - | - |
Formazione di Mark Gaffney
| University of Pennsylvania | Undergraduate Degree |
| Boston University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 2 |
| Israele | 2 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Virtual Software Systems, Inc.
Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Technology Services |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Mark Gaffney
- Esperienza
